Taken together, our findings suggest that Cpt1a inhibition can significantly inhibit tumor growth, promote apoptosis, and reduce the occurrence of lung metastases when combined with a ketogenic diet or HER2 monoclonal antibody therapy. This evidence concerns the gene ERBB2 and neoplasm.